CHRONOSCALE HOLDINGS CORP
CHRNNASDAQTrading Snapshot
- Day Range
- $14.99 β $17.10
- 52-Week Range
- $12.27 β $30.00
- Volume (shares)
- 180,401
- Avg Volume (shares)
- β
- Shares Outstanding
- 145.6M
- Next Earnings
- 2027-02-22
Fundamentals Snapshot
- Annual Revenue
- β
- Last Q Revenue
- $41M
- P/E Ratio
- β
- P/S Ratio
- 209.9x
- EPS (TTM)
- $-5.18
- Dividend Yield
- β
CHRONOSCALE HOLDINGS CORP
CHRNFinancial history unavailable.
About CHRONOSCALE HOLDINGS CORP
ChronoScale Corporation designs and develops a compute platform to support artificial intelligence (AI) workloads. The company focuses on large-scale deployments and provides dedicated compute environments engineered for performance, consistency, and long-term operational execution. The company is based in Dallas, Texas. ChronoScale Corporation operates as a subsidiary of Applied Digital Corporation.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Analyst Ratings
βLatest News & Updates

Soluna Agrees to Form Strategic Partnership with Applied Digital to Develop Wind-Powered AI Data Center in Texas
/PRNewswire/ -- Soluna Holdings, Inc. (Nasdaq: SLNH) ("Soluna"), a developer of green data centers for intensive computing applications including artificial

ChronoScale Reports Fiscal First Quarter 2027 Results
MENLO PARK, Calif., Oct. 15, 2026 (GLOBE NEWSWIRE) -- ChronoScale Holdings Corporation (NASDAQ: CHRN) (βChronoScaleβ or the βCompanyβ), an accelerated compute platform purpose-built to support demanding artificial intell

Wandercraft Acquires Ekso Bionics, Uniting Two Pioneers to Advance and Expand Robotic Mobility
NEW YORK and SAN RAFAEL, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Wandercraft today announced the acquisition of Ekso Bionics, Inc. from a subsidiary of ChronoScale Holdings Corporation (Nasdaq: CHRN), bringing together

ChronoScale Announces Agreements Bringing Total Company Contracted Run-Rate Revenue to $1 Billion and Sale of Ekso Bionics Business Unit
Expanded agreement with an existing AI infrastructure customer and new customer agreement increases contracted deployment pipeline and is expected to drive Company annualized revenue run rate to $1 billion by calendar Q3

Is Applied Digital Stock a Buy?
The artificial intelligence infrastructure specialist is growing sales, but its stock is down more than 50% from its 52-week high.

ChronoScale Announces AI Infrastructure Partnership with Microsoft for 50 MW AI Compute Deployment in North America
MENLO PARK, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- ChronoScale Corporation (NASDAQ: CHRN), (βChronoScaleβ or the βCompanyβ), an accelerated compute platform purpose-built to support demanding artificial intelligence w